Good article with a silly conclusion...
"This could signal an unsustainable business model, selling low-margin commodity devices into a saturated market; or it could be the signs of a company on the launch pad, just starting to roll out a game-changer in the syringe space."
The editor actually thinks that unis could have an unstable business model? Of course it's the latter..